The diagnosis and management of H. pylori infection in Singapore
- PMID: 28536725
- PMCID: PMC5435840
- DOI: 10.11622/smedj.2017037
The diagnosis and management of H. pylori infection in Singapore
Abstract
Helicobacter pylori (H. pylori) is an infection that has a role in causing dyspepsia and complications such as peptic ulcer disease and gastric malignancies. In the primary care setting, one can adopt a stepwise approach with the 'test-and-treat' strategy to manage H. pylori-associated dyspepsia in young patients without alarm symptoms. Empiric first-line therapies should be for a two-week duration; options include clarithromycin-containing triple therapy alone or with the addition of bismuth, concomitant therapy and bismuth quadruple therapy. Post-treatment carbon urea breath test must be performed at least four weeks after the end of treatment to confirm the cure. Options for empiric second-line treatment include bismuth quadruple therapy and levofloxacin-containing triple therapy. Patients with persistent or alarm symptoms should be referred for further evaluation. Patients with persistent infection should be referred for gastroscopy so that gastric biopsies can be obtained for H. pylori culture and antibiotic susceptibility testing.
Keywords: H. pylori; acid suppression; antibiotic resistance; dyspepsia.
Copyright: © Singapore Medical Association.
Figures
Similar articles
-
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.Dig Dis Sci. 2020 Jul;65(7):1917-1931. doi: 10.1007/s10620-020-06193-7. Dig Dis Sci. 2020. PMID: 32170476 Review.
-
Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.Eur J Gastroenterol Hepatol. 2015 Mar;27(3):221-5. doi: 10.1097/MEG.0000000000000186. Eur J Gastroenterol Hepatol. 2015. PMID: 25629566 Clinical Trial.
-
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.J Dig Dis. 2007 Nov;8(4):211-5. doi: 10.1111/j.1751-2980.2007.00308.x. J Dig Dis. 2007. PMID: 17970879 Clinical Trial.
-
[Helicobacter pylori - 2012].Orv Hetil. 2012 Sep 9;153(36):1407-18. doi: 10.1556/OH.2012.29443. Orv Hetil. 2012. PMID: 22951408 Review. Hungarian.
-
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.Scand J Gastroenterol. 2013 Jun;48(6):652-6. doi: 10.3109/00365521.2013.786132. Epub 2013 Apr 5. Scand J Gastroenterol. 2013. PMID: 23556551 Clinical Trial.
Cited by
-
Helicobacter pylori Treatment Strategies in Singapore.Gut Liver. 2021 Jan 15;15(1):13-18. doi: 10.5009/gnl19308. Gut Liver. 2021. PMID: 31875670 Free PMC article. Review.
-
Population- and Gender-Based Investigation for Prevalence of Helicobacter pylori in Dhamar, Yemen.Can J Gastroenterol Hepatol. 2023 Jan 25;2023:3800810. doi: 10.1155/2023/3800810. eCollection 2023. Can J Gastroenterol Hepatol. 2023. PMID: 36742348 Free PMC article.
-
Prevalence, Management, and Outcomes of Non-Invasive Helicobacter pylori Testing in Children at a Tertiary Paediatric Hospital in Singapore.Pediatr Gastroenterol Hepatol Nutr. 2024 Nov;27(6):336-344. doi: 10.5223/pghn.2024.27.6.336. Epub 2024 Nov 5. Pediatr Gastroenterol Hepatol Nutr. 2024. PMID: 39563839 Free PMC article.
-
Clinical audit of current Helicobacter pylori treatment outcomes in Singapore.Singapore Med J. 2022 Sep;63(9):503-508. doi: 10.11622/smedj.2021105. Epub 2021 Sep 21. Singapore Med J. 2022. PMID: 34544212 Free PMC article.
-
Vitamin C: A Preventative, Therapeutic Agent Against Helicobacter pylori.Cureus. 2018 Jul 30;10(7):e3062. doi: 10.7759/cureus.3062. Cureus. 2018. PMID: 30280058 Free PMC article. Review.
References
-
- Tonkic A, Tonkic M, Lehours P, Mégraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter. 2012;17(Suppl 1):1–8. - PubMed
-
- Ang TL, Fock KM, Ang D, et al. The changing profile of Helicobacter pylori antibiotic resistance in Singapore: a 15-year study. Helicobacter. 2016;21:261–5. - PubMed
-
- Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–86. - PubMed
-
- Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6–30. - PubMed
-
- Gisbert JP, Khorrami S, Carballo F, et al. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther. 2004;19:617–29. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases